| Company | Archer-Daniels-Midland Company (NYSE: ADM) |
| Regulator | U.S. Securities and Exchange Commission |
| Action | Settled charges — accounting and disclosure fraud |
| Settlement | $40 million civil penalty (January 27, 2026) |
| Period | Fiscal years 2019 – 2022 |
| Segment | Nutrition (Human and Animal Nutrition) |
| Individuals | Vince Macciocchi, Ray Young (settled); Vikram Luthar (litigated) |
A growth story that needed protecting
ADM is one of the world's largest agricultural processing companies — grain, oilseeds, animal feed, human nutrition ingredients, sold to food manufacturers across the globe. For years, investors were told that Nutrition was the future. Not the legacy grain business. Not the commodity trading floors. Nutrition: the higher-margin, faster-growing segment that justified the premium ADM commanded.
The Nutrition division was being touted as delivering 15% to 20% operating profit growth per year. That target was communicated to the market. Analysts built models around it. The segment was the narrative engine of ADM's investment case.
The problem, according to the SEC, was that Nutrition wasn't actually delivering those numbers on its own.
What intersegment transactions are — and why they matter
Large companies with multiple business divisions often trade with each other internally. ADM's Nutrition segment, for instance, buys raw materials from ADM's Agricultural Services segment. These are real transactions — but they happen entirely within the same corporate boundary.
Accounting standards require that such intersegment sales be conducted at arm's length — prices that approximate what an independent third party would pay. This is not optional. It is a prerequisite for segment reporting to mean anything. When a company reports "Nutrition operating profit: $X," investors are entitled to assume that the costs Nutrition paid for inputs from sister divisions were real market prices, not artificial ones.
When prices between your own divisions are not real, the profits in each division are not real either. The consolidation cancels it out. The segment report does not.
Here is the critical structural point: intersegment transactions eliminate on consolidation. In the consolidated P&L, the profit that Nutrition gains from a below-market purchase from Agriculture is exactly offset by the margin Agriculture loses. Total group profit is unchanged.
But segment-level reporting is not consolidated. Each segment is reported on its own. So if you manipulate the price at which Nutrition buys from Agriculture, you can transfer profit from one segment to another — invisibly, at the group level.
The mechanism: retroactive rebates and price adjustments
The SEC's complaint against former executive Vikram Luthar is specific. When Nutrition was falling short of its operating profit targets for fiscal years 2021 and 2022, adjustments were directed to the intersegment transactions. These adjustments included retroactive rebates and price changes that were not customarily available to third-party customers.
In plain terms: after the fact, after the transactions had already been recorded, the prices were changed. Agriculture was made to sell to Nutrition more cheaply, or give back money already earned, in amounts calculated to close the gap between Nutrition's actual results and its targets.
This is what the adjusted journal entry would have looked like:
The adjustments were not offered to external customers. An independent food manufacturer buying from ADM could not call up and demand a retroactive rebate because a target was being missed. That option existed only within the group — which is precisely why it was not arm's length, and precisely why it was fraud.
Why auditors were looking in the wrong place
This is the forensic lesson that every CA and auditor should carry from this case.
Standard audit procedures are designed around the consolidated entity. Revenue completeness testing, cost cut-off procedures, receivables confirmation, inventory counts — these all operate at the consolidated level or at the individual legal entity level. They are not, by default, designed to interrogate the pricing terms of transactions between two divisions of the same company.
The ADM manipulation was invisible to consolidated audit tests because it cancelled out in consolidation. Group profit was not affected. No revenue was manufactured from thin air in the consolidated accounts. The only place the effect appeared was in segment reporting — which typically receives far less substantive audit attention than the primary financial statements.
Segment reporting lives in the notes. Auditors test that the segmentation methodology is consistently applied and that the numbers add up to the consolidated total. What they do not routinely do is verify that every intersegment price approximates an arm's-length market price.
That gap — between what segment reporting requires and what audit procedures actually test — was the space in which this fraud operated for at least four years.
The numbers behind the growth story
ADM was not a small company hoping nobody would notice. This is a global agribusiness processing billions of dollars of commodities annually. Nutrition was a strategically important segment, publicly positioned as a growth engine, cited in earnings calls, and used to anchor the investment thesis presented to institutional investors.
The SEC found that the manipulation inflated Nutrition's reported performance across fiscal years 2019 through 2022. ADM subsequently restated its financials — twice. The company also dismissed its Chief Financial Officer and experienced significant share price erosion before the matter reached settlement.
What the company did right — eventually
The SEC specifically noted ADM's cooperation and significant remedial measures, including self-reporting the matter, implementing a comprehensive new compliance programme, and terminating employees involved in the misconduct. This cooperation is why the penalty, at $40 million, was less severe than it might otherwise have been.
Self-reporting is not nothing. It takes institutional courage to surface a fraud internally and then walk it into the regulator's office. But it does not change the years during which the misrepresentation stood — and it does not change what investors were told, and acted on, in the interim.
What to Watch For
- Segment margins that consistently meet or slightly beat analyst targets — especially in a segment the company has publicly positioned as a growth driver. Real businesses are lumpy. Perfect delivery is a signal.
- Intersegment eliminations that are large relative to segment revenue, or that move significantly year-over-year without explanation in the notes.
- Retroactive adjustments to prior-period intersegment transactions, disclosed (if at all) only in footnotes.
- Segment profitability that looks dramatically different from listed peers operating the same business independently. If your competitor runs that division at 8% margins and you're reporting 18%, the difference needs a real explanation.
- Leadership turnover concentrated in the finance function of a high-profile segment. ADM's CFO departure was a visible signal — in hindsight.
The consolidation cancelled it out. The segment report did not. That asymmetry is where the fraud lived.
Next week, Edition 03: the other half of the ADM story — who had the incentive to do this, what their bonus structures looked like, and why the audit committee did not catch it for four years. The mechanism tells you how. The incentive tells you why. Both matter.
SEC Press Release No. 2026-15 (Jan. 27, 2026): SEC Charges ADM and Three Former Executives with Accounting and Disclosure Fraud · ADM Form 8-K, Exhibit 99.1 (Jan. 27, 2026): ADM Announces Closure of Government Investigations · Michael Volkov, "When Financial Controls Fail: The SEC's ADM Settlement" — Volkov Law Blog (Mar. 5, 2026) · Bloomberg: "ADM to Pay $40 Million to Settle SEC Accounting Fraud Probe" (Jan. 28, 2026)